川崎病合并冠状动脉病变危险因素的多中心回顾性研究

张伦敏, 彭粤, 苏建军, 易岂建

PDF(490 KB)
PDF(490 KB)
重庆医科大学学报 ›› 2025, Vol. 50 ›› Issue (01) : 94-97. DOI: 10.13406/j.cnki.cyxb.003662
临床研究

川崎病合并冠状动脉病变危险因素的多中心回顾性研究

作者信息 +

Risk factors for Kawasaki disease comorbid with coronary artery lesion: a multicenter retrospective study

Author information +
History +

摘要

目的 通过对川崎病(kawasaki disease,KD)患儿临床特征及实验室指标分析,探讨KD合并冠状动脉损害(coronary artery lesions,CAL)的危险因素。 方法 选取2023年6月至2024年6月住院治疗的346例KD患儿为研究对象,其中遵义市第一人民医院住院患儿134例,重庆医科大学附属儿童医院住院患儿212例,根据有无CAL分为KD有CAL(KD-CAL)组和KD无CAL(KD-NCAL)组,对2组临床特征及实验室指标行差异性分析,共线性分析及多因素Logistic回归分析。 结果 KD-CAL组与KD-NCAL组在年龄、免疫球蛋白(intravenous immunoglobulin,IVIG)冲击时间、皮疹、口唇变化、球结膜充血、四肢末梢改变、白细胞(white blood cell,WBC)、血红蛋白(hemoglobin,Hb)、中性粒细胞比例(N%)、血小板(platelet,PLT)、C反应蛋白(c-reactive protein,CRP)、红细胞沉降率(erythrocyte sedimentation rate,ESR)、丙氨酸氨基转氨酶(alanine aminotransferase,ALT)、血钠(Na)方面差异无统计学意义(P>0.05),而在性别、颈淋巴结肿大、高降钙素原(procalcitonin,PCT)、白蛋白(albumin,ALB)方面差异有统计学意义(P<0.05)。随后,多因素logistic回归分析结果显示男性(OR=1.886;95%CI=1.198~2.971;P=0.006),ALB(OR=0.938;95%CI=0.894~0.983;P=0.008)和PCT(OR=1.107;95%CI=1.007~1.207;P=0.035)与KD患者出现CAL独立相关。 结论 男性、低ALB、PCT是KD患儿合并CAL的独立危险因素。对于这类KD患儿,需要积极地早期干预避免后期CAL的发生。

Abstract

Objective To investigate the risk factors for Kawasaki disease(KD) comorbid with coronary artery lesion(CAL) by analyzing the clinical features and laboratory markers of children with KD. Methods A total of 346 children with KD who were hospitalized for treatment from June 2023 to June 2024 were enrolled as subjects,among whom there were 134 children from The First People’s Hospital of Zunyi and 212 children from Children’s Hospital of Chongqing Medical University. According to the presence or absence of CAL,the children were divided into KD group with CAL(KD-CAL group) and KD group without CAL(KD-NCAL group). A difference analysis,a collinearity analysis,and the multivariate logistic regression analysis were performed for the clinical features and laboratory markers of the two groups. Results There were no significant differences between the KD-CAL group and the KD-NCAL group in age,time of intravenous immunoglobulin shock therapy,rash,lip changes,bulbar conjunctival hyperemia,peripheral changes of limbs,white blood cell count,hemoglobin,percentage of neutrophils,platelet count,C-reactive protein,erythrocyte sedimentation rate,alanine aminotransferase,and blood sodium(P>0.05),while there were significant differences between the two groups in sex,cervical lymphadenectasis,procalcitonin(PCT),and albumin(ALB)(P<0.05). The subsequent multivariate logistic regression analysis showed that male sex(odds ratio[OR]=1.886,95%CI=1.198-2.971,P=0.006),ALB(OR=0.938,95%CI=0.894-0.983,P=0.008),and PCT(OR=1.107,95%CI=1.007-1.207,P=0.035) were independently associated with the presence of CAL in patients with KD. Conclusion Male sex,low ALB,and high PCT are independent risk factors for CAL in children with KD,and for such children,early intervention should be actively performed to avoid CAL.

关键词

川崎病 / 冠状动脉 / 临床表现 / 实验室指标 / 危险因素

Key words

Kawasaki disease / coronary artery / clinical features / laboratory markers / risk factor

中图分类号

R725.4

引用本文

导出引用
张伦敏 , 彭粤 , 苏建军 , . 川崎病合并冠状动脉病变危险因素的多中心回顾性研究. 重庆医科大学学报. 2025, 50(01): 94-97 https://doi.org/10.13406/j.cnki.cyxb.003662
Zhang Lunmin, Peng Yue, Su Jianjun, et al. Risk factors for Kawasaki disease comorbid with coronary artery lesion: a multicenter retrospective study[J]. Journal of Chongqing Medical University. 2025, 50(01): 94-97 https://doi.org/10.13406/j.cnki.cyxb.003662

参考文献

1
Kuo HC. Diagnosis,progress,and treatment update of Kawasaki disease[J]. Int J Mol Sci202324(18):13948.
2
McCrindle BW Li JS Minich LL,et al. Coronary artery involvement in children with Kawasaki disease:risk factors from analysis of serial normalized measurements[J]. Circulation2007116(2):174-179.
3
赵胜超,黄兴楚. 川崎病合并冠状动脉病变危险因素分析[J]. 中国继续医学教育202012(32):144-147.
Zhao SC Huang XC. Risk factors of Kawasaki disease complicated with coronary artery disease[J]. China Continuing Med Educ202012(32):144-147.
4
周翠臻,宋思瑞,陈丽琴,等. 川崎病合并冠状动脉瘤危险因素分析[J]. 临床儿科杂志202341(7):498-501,518.
Zhou CZ Song SR Chen LQ,et al. Risk factors analysis of coronary artery aneurysm occurrence in children with Kawasaki disease[J]. J Clin Pediatr202341(7):498-501,518.
5
Holve TJ Patel A Chau Q,et al. Long-term cardiovascular outcomes in survivors of Kawasaki disease[J]. Pediatrics2014133(2):e305-e311.
6
Lin MT Sun LC Wu ET,et al. Acute and late coronary outcomes in 1073 patients with Kawasaki disease with and without intravenous γ-immunoglobulin therapy[J]. Arch Dis Child2015100(6):542-547.
7
Jakob A von Kries R Horstmann J,et al. Failure to predict high-risk Kawasaki disease patients in a population-based study cohort in Germany[J]. Pediatr Infect Dis J201837(9):850-855.
8
McCrindle BW Rowley AH Newburger JW,et al. Diagnosis,treatment,and long-term management of Kawasaki disease:a scientific statement for health professionals from the American heart association[J]. Circulation2017135(17):e927-e999.
9
Rife E Gedalia A. Kawasaki disease:an update[J]. Curr Rheumatol Rep202022(10):75.
10
Mavrogeni S Papadopoulos G Hussain T,et al. The emerging role of cardiovascular magnetic resonance in the evaluation of Kawasaki disease[J]. Int J Cardiovasc Imaging201329(8):1787-1798.
11
Xia YH Qiu HX Wen ZW,et al. Albumin level and progression of coronary artery lesions in Kawasaki disease:a retrospective cohort study[J]. Front Pediatr202210:947059.
12
Tai IH Wu PL Guo MM,et al. Prognostic nutrition index as a predictor of coronary artery aneurysm in Kawasaki Disease[J]. BMC Pediatr202020(1):203.
13
Dominguez SR Martin B Heizer H,et al. Procalcitonin (PCT) and Kawasaki disease:does PCT correlate with IVIG-resistant disease,admission to the intensive care unit,or development of coronary artery lesions?[J]. J Pediatric Infect Dis Soc20165(3):297-302.
14
Pan Y Fan Q. The role of procalcitonin for predicting Kawasaki disease[J]. Fetal Pediatr Pathol202241(6):1015-1022.
15
Miyata K Miura M Kaneko T,et al. Risk factors of coronary artery abnormalities and resistance to intravenous immunoglobulin plus corticosteroid therapy in severe Kawasaki disease:an analysis of post RAISE[J]. Circ Cardiovasc Qual Outcomes202114(2):e007191.
16
Iio K Morikawa Y Miyata K,et al. Risk factors of coronary artery aneurysms in Kawasaki disease with a low risk of intravenous immunoglobulin resistance:an analysis of PostRAISE[J]. J Pediatr2022240:158-163. e4.
17
Tang YJ Ding CX Xu QQ,et al. Prediction nomogram for coronary artery aneurysms at one month in Kawasaki disease[J]. Ital J Pediatr202349(1):146.

基金

国家儿童健康与疾病临床医学研究中心基金资助项目(NCRC-2020-GP-02)

评论

PDF(490 KB)

Accesses

Citation

Detail

段落导航
相关文章

/